FisichellaM, BerenguerF, SteinmetzG, et al.Toxicity evaluation of manufactured CeO2 nanoparticles before and after alteration: combined physicochemical and whole-genome expression analysis in Caco-2 cells. BMC Genomics, 2014; 15:700.
2.
MinghettiL, Ajmone-CatMA, De BerardinisMA, et al.Microglial activation in chronic neurodegenerative diseases: roles of apoptotic neurons and chronic stimulation. Brain Res Brain Res Rev, 2005; 48:251–256.
3.
SteimbergN, BerteroA, ChionoV, et al.iPS, organoids and 3D models as advanced tools for in vitro toxicology. ALTEX, 2020; 37:136–140.
4.
AbreuCM, GamaL, KrasemannS, et al.Microglia increase inflammatory responses in iPSC-derived human BrainSpheres. Front Microbiol, 2018; 9:2766.
5.
HuhD, LeslieDC, MatthewsBD, et al.A human disease model of drug toxicity-induced pulmonary edema in a lung-on-a-chip microdevice. Sci Transl Med, 2012; 4:159ra47.
6.
EschEW, BahinskiA, HuhD. Organs-on-chips at the frontiers of drug discovery. Nat Rev Drug Discov, 2015; 14:248–260.
7.
SarkarS, LeoBF, CarranzaC, et al.Modulation of human macrophage responses to mycobacterium tuberculosis by silver nanoparticles of different size and surface modification. PLoS One, 2015; 10:e0143077.
8.
CedilakM, BanjanacM, BelamaricD, et al.Precision-cut lung slices from bleomycin treated animals as a model for testing potential therapies for idiopathic pulmonary fibrosis. Pulm Pharmacol Ther, 2019; 55:75–83.
9.
PamiesD, Bal-PriceA, ChesnéC, et al.Advanced good cell culture practice for human primary, stem cell-derived and organoid models as well as microphysiological systems. ALTEX, 2018; 35:353–378.
10.
KangCC, YamauchiKA, VlassakisJ, et al.Single cell-resolution western blotting. Nat Protoc, 2016; 11:1508–1530.
11.
MukherjeeD, BotelhoD, GowAJ, ZhangJ, GeorgopoulosPG. Computational multiscale toxicodynamic modeling of silver and carbon nanoparticle effects on mouse lung function. PLoS One, 2013; 8:e80917.
